Orly Lipsitz

7.5k total citations · 2 hit papers
51 papers, 4.8k citations indexed

About

Orly Lipsitz is a scholar working on Pharmacology, Biological Psychiatry and Experimental and Cognitive Psychology. According to data from OpenAlex, Orly Lipsitz has authored 51 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pharmacology, 28 papers in Biological Psychiatry and 20 papers in Experimental and Cognitive Psychology. Recurrent topics in Orly Lipsitz's work include Treatment of Major Depression (35 papers), Tryptophan and brain disorders (28 papers) and Mental Health Research Topics (18 papers). Orly Lipsitz is often cited by papers focused on Treatment of Major Depression (35 papers), Tryptophan and brain disorders (28 papers) and Mental Health Research Topics (18 papers). Orly Lipsitz collaborates with scholars based in Canada, Singapore and China. Orly Lipsitz's co-authors include Roger S. McIntyre, Hartej Gill, Leanna M.W. Lui, Flora Nasri, Roger Ho, David Chen‐Li, Amna Majeed, Jiaqi Xiong, Lee Phan and Michelle Iacobucci and has published in prestigious journals such as Neuroscience & Biobehavioral Reviews, Journal of Affective Disorders and Psychopharmacology.

In The Last Decade

Orly Lipsitz

49 papers receiving 4.7k citations

Hit Papers

Impact of COVID-19 pandemic on mental health in the gener... 2020 2026 2022 2024 2020 2021 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Impact of COVID-19 pandemic on mental health in the general population: A systematic review
    2020 3.5k citations Jiaqi Xiong, Orly Lipsitz et al. Journal of Affective Disorders profile →
  2. Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries
    2021 157 citations Yena Lee, Leanna M.W. Lui et al. Journal of Affective Disorders profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Orly Lipsitz Canada 20 3.1k 928 733 687 684 51 4.8k
Flora Nasri Canada 22 3.3k 1.1× 1.1k 1.2× 798 1.1× 520 0.8× 817 1.2× 47 5.2k
David Chen‐Li Canada 14 3.0k 1.0× 918 1.0× 638 0.9× 352 0.5× 678 1.0× 23 4.3k
Gabriele Sani Italy 43 3.2k 1.0× 708 0.8× 795 1.1× 839 1.2× 489 0.7× 279 6.9k
Lee Phan Canada 15 2.8k 0.9× 908 1.0× 694 0.9× 325 0.5× 656 1.0× 46 4.2k
Konstantinos Ν. Fountoulakis Greece 50 2.6k 0.8× 979 1.1× 970 1.3× 958 1.4× 1.0k 1.5× 303 8.6k
Luigi Janiri Italy 48 2.9k 1.0× 718 0.8× 942 1.3× 826 1.2× 495 0.7× 261 7.8k
Leanna M.W. Lui Canada 31 4.1k 1.3× 1.1k 1.2× 1.0k 1.4× 805 1.2× 784 1.1× 77 7.1k
Amna Majeed Canada 15 3.0k 1.0× 1.0k 1.1× 671 0.9× 235 0.3× 795 1.2× 26 4.9k
Michelle Iacobucci Canada 17 2.8k 0.9× 924 1.0× 740 1.0× 245 0.4× 662 1.0× 26 4.4k
Leo Sher United States 47 5.5k 1.8× 1.5k 1.7× 1.1k 1.4× 723 1.1× 835 1.2× 287 9.8k

Countries citing papers authored by Orly Lipsitz

Since Specialization
Citations

This map shows the geographic impact of Orly Lipsitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orly Lipsitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orly Lipsitz more than expected).

Fields of papers citing papers by Orly Lipsitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orly Lipsitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orly Lipsitz. The network helps show where Orly Lipsitz may publish in the future.

Co-authorship network of co-authors of Orly Lipsitz

This figure shows the co-authorship network connecting the top 25 collaborators of Orly Lipsitz. A scholar is included among the top collaborators of Orly Lipsitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orly Lipsitz. Orly Lipsitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schulz, Christian, et al.. (2025). Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression. Journal of Psychopharmacology. 39(9). 950–956.
2.
McIntyre, Roger S., Orly Lipsitz, Nelson B. Rodrigues, et al.. (2022). An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study. JMIR Mental Health. 9(10). e33871–e33871. 3 indexed citations
3.
El‐Halabi, Sabine, Daniel Cooper, S. Danielle, et al.. (2021). The effects of antidepressant medications on antiretroviral treatment adherence in HIV-positive individuals with depression. Journal of Affective Disorders. 300. 219–225. 6 indexed citations
4.
Vincenzo, Joshua D. Di, Kayla M. Teopiz, Yena Lee, et al.. (2021). Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects. Psychiatry Research. 306. 114231–114231. 16 indexed citations
5.
Rodrigues, Nelson B., Roger S. McIntyre, Orly Lipsitz, et al.. (2021). Do sleep changes mediate the anti‐depressive and anti‐suicidal response of intravenous ketamine in treatment‐resistant depression?. Journal of Sleep Research. 31(1). e13400–e13400. 16 indexed citations
6.
7.
Siegel, Ashley, Shakila Meshkat, Orly Lipsitz, et al.. (2021). Registered clinical studies investigating psychedelic drugs for psychiatric disorders. Journal of Psychiatric Research. 139. 71–81. 60 indexed citations
8.
Vincenzo, Joshua D. Di, Ashley Siegel, Orly Lipsitz, et al.. (2021). The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. Journal of Psychiatric Research. 137. 232–241. 40 indexed citations
9.
Lee, Yena, Leanna M.W. Lui, David Chen‐Li, et al.. (2021). Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries. Journal of Affective Disorders. 290. 364–377. 157 indexed citations breakdown →
10.
McIntyre, Roger S., Orly Lipsitz, Leanna M.W. Lui, et al.. (2021). The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine. Journal of Affective Disorders. 294. 592–596. 11 indexed citations
11.
Ng, Jason, Joshua D. Rosenblat, Leanna M.W. Lui, et al.. (2021). Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review. Journal of Affective Disorders. 293. 285–294. 36 indexed citations
12.
Lui, Leanna M.W., Yena Lee, Orly Lipsitz, et al.. (2021). The influence of prescriber and patient gender on the prescription of benzodiazepines: results from the Florida Medicaid Dataset. CNS Spectrums. 27(3). 378–382. 4 indexed citations
13.
Ng, Jason, Leanna M.W. Lui, Joshua D. Rosenblat, et al.. (2021). Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment. Psychopharmacology. 238(4). 917–926. 23 indexed citations
14.
15.
Xiong, Jiaqi, Orly Lipsitz, Flora Nasri, et al.. (2020). Impact of COVID-19 pandemic on mental health in the general population: A systematic review. Journal of Affective Disorders. 277. 55–64. 3542 indexed citations breakdown →
16.
Gill, Hartej, Carlos Daniel Pérez, Barjot Gill, et al.. (2020). The Prevalence of Suicidal Behaviour in Fibromyalgia Patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 108. 110078–110078. 9 indexed citations
17.
Gill, Hartej, Barjot Gill, Nelson B. Rodrigues, et al.. (2020). The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research. Neuroscience & Biobehavioral Reviews. 120. 78–85. 60 indexed citations
18.
Subramaniapillai, Mehala, Caroline Park, Orly Lipsitz, et al.. (2020). Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder. Journal of Affective Disorders. 282. 448–453. 14 indexed citations
19.
Rodrigues, Nelson B., Ashley Siegel, Orly Lipsitz, et al.. (2020). Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation. CNS Spectrums. 27(3). 315–321. 9 indexed citations
20.
Siegel, Ashley, Nelson B. Rodrigues, Flora Nasri, et al.. (2020). Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 104. 110032–110032. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Flora Nasri Breakdown of academic impact, for papers by David Chen‐Li Breakdown of academic impact, for papers by Gabriele Sani Breakdown of academic impact, for papers by Lee Phan Breakdown of academic impact, for papers by Konstantinos Ν. Fountoulakis Breakdown of academic impact, for papers by Luigi Janiri Breakdown of academic impact, for papers by Leanna M.W. Lui Breakdown of academic impact, for papers by Amna Majeed Breakdown of academic impact, for papers by Michelle Iacobucci Breakdown of academic impact, for papers by Leo Sher
Rankless by CCL
2026